SCHEMBL8316099

SCHEMBL8316099

Cc1ccc(OS)cc1C(N)=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.44
TDP1 Q9NUW8 2/20 0.42
SIRT3 Q9NTG7 1/20 0.42
KDM4E B2RXH2 2/20 0.40
MAPK1 P28482 1/20 0.38
CASP1 P29466 1/20 0.38
NNMT P40261 3/20 0.38
PARP10 Q53GL7 3/20 0.37
PARP4 Q9UKK3 2/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
PARP1 P09874 1/20 0.37
PARP2 Q9UGN5 1/20 0.37
KMT2A Q03164 4/20 0.36
MEN1 O00255 3/20 0.36
IRAK4 Q9NWZ3 1/20 0.36
ALDH1A1 P00352 1/20 0.35
PARP15 Q460N3 1/20 0.35
PARP14 Q460N5 1/20 0.35
PARP16 Q8N5Y8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2855495 0.83 KDM4E (0.55) SMN1; SMN2KDM4EMAPK1CASP1NNMT
SCHEMBL13870124 0.79 ALDH1A1 (0.48) SMN1; SMN2TDP1PARP10PARP4PARP2
SCHEMBL31557923 0.77 PARP10 (0.56) SMN1; SMN2TDP1MAPK1PARP10PARP4
SCHEMBL12569554 0.77 CHEK1 (0.46) SMN1; SMN2KDM4EKMT2A
Hydrochloric Acid SCHEMBL27696847 0.76 PARP10 (0.54) PARP10PARP4PARP2KMT2AALDH1A1
SCHEMBL5550268 0.76 SMN1; SMN2 (0.46) SMN1; SMN2CA1KMT2AMEN1MAPT
SCHEMBL1003845 0.74 MEN1 (0.53) SMN1; SMN2TDP1SIRT3KDM4EMAPK1
SCHEMBL30343857 0.73 KDM4E (0.52) SMN1; SMN2TDP1KDM4EALDH1A1
SCHEMBL328278 0.72 CASP1 (0.50) TDP1SIRT3KDM4EMAPK1CASP1
SCHEMBL4950195 0.72 TDP1 (0.47) SMN1; SMN2TDP1SIRT3KDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004083177-A2 LINEAR CHAIN SUBSTITUTED MONOCYCLIC AND BICYCLIC DERIVATIVES AS FACTOR XA INHIBITORS BRYSTOL-MYERS SQUIBB COMPANY (US) 2004-09-30 WO disclosed